Literature DB >> 5454765

Cephalexin in patients with renal disease.

J A Linquist, J Y Siddiqui, I M Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5454765     DOI: 10.1056/NEJM197010012831402

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

Review 2.  Cephalexin: a review of its antibacterial, pharmacological and therapeutic properties.

Authors:  T M Speight; R N Brogden; G S Avery
Journal:  Drugs       Date:  1972       Impact factor: 9.546

3.  Effectiveness and tolerance of cephalexin in children.

Authors:  H Helwig; H Kunz; C Hueppchen
Journal:  Z Kinderheilkd       Date:  1972

4.  Pharmacokinetics of cefaclor in patients with end stage renal disease and during hemodialysis.

Authors:  S J Berman; W H Boughton; J G Sugihara; E G Wong; M M Sato; A W Siemsen
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

5.  The administration of cephradine to patients in renal failure.

Authors:  A E Solomon; J D Briggs
Journal:  Br J Clin Pharmacol       Date:  1975-10       Impact factor: 4.335

6.  Pharmacology of cefaclor in normal volunteers and patients with renal failure.

Authors:  J Santoro; B N Agarwal; R Martinelli; N Wenger; M E Levison
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

7.  Pharmacokinetics of cefamandole in patients with renal failure.

Authors:  B R Meyers; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.